Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015 (2015), Article ID 938264, 3 pages
http://dx.doi.org/10.1155/2015/938264
Case Report

Postinjection Muscle Fibrosis from Lupron

1Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
2Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA

Received 14 March 2015; Accepted 13 May 2015

Academic Editor: Giovanni Montini

Copyright © 2015 Erica Everest et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Fuqua, “Treatment and outcomes of precocious puberty: an update,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6, pp. 2198–2207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Lupron Depot, leuprolide acetate for depot suspension, 2013, http://www.lupron.com/.
  3. S. R. Johnson, R. C. Nolan, M. T. Grant et al., “Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty,” Journal of Paediatrics and Child Health, vol. 48, no. 3, pp. E136–E139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. N. Menon and M. Vijayakumar, “Precocious puberty—perspectives on diagnosis and management,” Indian Journal of Pediatrics, vol. 81, no. 1, pp. 76–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Carel, E. A. Eugster, A. Rogol, L. Ghizzoni, and M. R. Palmert, “Consensus statement on the use of gonadotropin-releasing hormone analogs in children,” Pediatrics, vol. 123, no. 4, pp. e752–e762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-C. Carel, N. Lahlou, M. Roger, and J. L. Chaussain, “Precocious puberty and statural growth,” Human Reproduction Update, vol. 10, no. 2, pp. 135–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Soriano-Guillén, R. Corripio, J. I. Labarta et al., “Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4305–4313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Teilmann, C. B. Pedersen, N. E. Skakkebæk, and T. K. Jensen, “Increased risk of precocious puberty in internationally adopted children in Denmark,” Pediatrics, vol. 118, no. 2, pp. 391–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Lee, K. Klein, N. Mauras et al., “36-month treatment experience of 2 doses of leuprolide acetate 3-month depot for children with central precocious puberty,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, pp. 3153–3159, 2014. View at Google Scholar
  10. W. W. Greulich and S. I. Pyle, Radiographic Atlas of Skeletal Development of Hand Wrist, vol. 2, Stanford University Press, Stanford, Calif, USA, 1971.
  11. P. S. Bergeson, S. A. Singer, and A. M. Kaplan, “Intramuscular injections in children,” Pediatrics, vol. 70, no. 6, pp. 944–948, 1982. View at Google Scholar · View at Scopus
  12. N. A. Mir, S. M. Ahmed, and J. A. Bhat, “Post-injection gluteal fibrosis: a neglected problem,” JK Science, vol. 4, no. 3, pp. 144–146, 2002. View at Google Scholar · View at Scopus
  13. R. Jerotic, G. Rikolic, S. Rejie et al., “Rehabilitation of post-injection contractures in children,” Srpski Arhiv za Celokupno Lekarstvo, vol. 103, p. 59, 1975. View at Google Scholar
  14. E. V. Alvarez, M. Munters, L. S. Lavine, H. Manes, and J. Waxman, “Quadriceps myofibrosis: a complication of intramuscular injections,” The Journal of Bone & Joint Surgery—American Volume, vol. 62, no. 1, pp. 58–60, 1980. View at Google Scholar · View at Scopus
  15. Abbott Laboratories, Lupron Depot Ped (leuprolide acetate for depot suspension), Abbott Laboratories, North Chicago, Ill, USA, 2008, http://www.rxabbvie.com/pdf/lupronpediatric.pdf.
  16. G. Tonini, S. Marinoni, V. Forleo, M. Rustico, E. K. Neely, and D. M. Wilson, “Local reactions to luteinizing hormone releasing hormone analog therapy,” The Journal of Pediatrics, vol. 126, no. 1, pp. 159–160, 1995. View at Google Scholar · View at Scopus
  17. E. K. Neely, R. L. Hintz, B. Parker et al., “Two-year results of treatment with depot leuprolide acetate for central precocious puberty,” Journal of Pediatrics, vol. 121, no. 4, pp. 634–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. T. J. Daskivich and W. K. Oh, “Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?” Urology, vol. 67, no. 5, pp. 1084.e15–1084.e17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Curry III and C. J. Sweeney, “Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer,” Journal of Urology, vol. 168, no. 1, p. 193, 2002. View at Publisher · View at Google Scholar · View at Scopus